CAMSAP1 and hepatocellular carcinoma: In line with this, Wang Wenwen et al. demonstrated that the AC145207.5/miR-101-3p axis can impede immune cell infiltration by upregulating CAMSAP1 expression, contributing to adverse outcomes in advanced hepatocellular carcinoma patients [44].